MedPath

Propagermanium

Generic Name
Propagermanium
Drug Type
Small Molecule
Chemical Formula
C6H10Ge2O7
CAS Number
12758-40-6
Unique Ingredient Identifier
1Q2P9TO9Q7

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Phase 3
Recruiting
Conditions
FSGS
Interventions
Drug: Placebo
First Posted Date
2022-01-10
Last Posted Date
2023-10-26
Lead Sponsor
Dimerix Bioscience Pty Ltd
Target Recruit Count
286
Registration Number
NCT05183646
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Action3 Investigator Site 6, Melbourne, Australia

๐Ÿ‡บ๐Ÿ‡ธ

ACTION3 Investigational Site 20, Coral Gables, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

ACTION3 Investigational Site 21, Springfield, Massachusetts, United States

and more 19 locations

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Phase 2
Terminated
Conditions
COVID-19
SARS-CoV2 Infection
Interventions
First Posted Date
2021-11-16
Last Posted Date
2023-09-15
Lead Sponsor
University of Sydney
Target Recruit Count
49
Registration Number
NCT05122182
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

DM Wayanad Institute of Medical Sciences, Meppadi, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Sterling Hospital, Nigdi, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Jivanrekha Multi-Speciality Hospital, Pune, India

and more 7 locations

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

Phase 2
Completed
Conditions
Focal Segmental Glomerulosclerosis
Interventions
First Posted Date
2018-08-28
Last Posted Date
2022-07-29
Lead Sponsor
Dimerix Bioscience Pty Ltd
Target Recruit Count
8
Registration Number
NCT03649152
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Westmead, Westmead, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Renal Research, Gosford, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Box Hill Hospital, Box Hill, Victoria, Australia

and more 8 locations

Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan

Phase 2
Completed
Conditions
Diabetic Kidney Disease
Interventions
First Posted Date
2018-08-13
Last Posted Date
2022-07-29
Lead Sponsor
Dimerix Bioscience Pty Ltd
Target Recruit Count
45
Registration Number
NCT03627715
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne Renal Research Group, Melbourne, Victoria, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Liverpool Hospital, Liverpool, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Royal North Shore Hospital, St Leonards, New South Wales, Australia

and more 10 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath